| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2010 | CN101679444A Xanthine compounds having a positive allosteric gabab receptor modulator effect |
| 03/24/2010 | CN101679442A Compounds for the treatment of hepatitis c |
| 03/24/2010 | CN101679441A Compounds for the treatment of hepatitis c |
| 03/24/2010 | CN101679440A Pyrrolopyrimidine derivatives as jak3 inhibitors |
| 03/24/2010 | CN101679439A P70 s6激酶抑制剂 P70 s6 kinase inhibitors |
| 03/24/2010 | CN101679437A cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 03/24/2010 | CN101679436A Fused ring heterocycle kinase modulators |
| 03/24/2010 | CN101679435A New compounds 892 |
| 03/24/2010 | CN101679434A 2, 6, 9-substituted purine derivatives having anti proliferative properties |
| 03/24/2010 | CN101679433A Novel adenine compound |
| 03/24/2010 | CN101679432A Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 03/24/2010 | CN101679430A 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-i receptor for the treatment of anxiety and depression |
| 03/24/2010 | CN101679429A 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer |
| 03/24/2010 | CN101679428A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 03/24/2010 | CN101679427A Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/24/2010 | CN101679426A 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
| 03/24/2010 | CN101679425A 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives |
| 03/24/2010 | CN101679424A 2, 6-naphthyridine derivatives as protein kinase modulators |
| 03/24/2010 | CN101679423A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 03/24/2010 | CN101679422A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 03/24/2010 | CN101679421A New imidazo[ 4,5-b]pyridine-7-carboxamides 704 |
| 03/24/2010 | CN101679418A [2, 6] naphthyridines useful as protein kinase inhibitors |
| 03/24/2010 | CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives |
| 03/24/2010 | CN101679416A Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu |
| 03/24/2010 | CN101679415A oxazolidinone antibiotics |
| 03/24/2010 | CN101679414A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 03/24/2010 | CN101679413A New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
| 03/24/2010 | CN101679412A Purinones and 1h-imidazopyridinones as PKC-theta inhibitors |
| 03/24/2010 | CN101679411A mapk/erk kinase inhibitors |
| 03/24/2010 | CN101679410A 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents |
| 03/24/2010 | CN101679409A New compounds |
| 03/24/2010 | CN101679408A Bicyclic heterocyclic compounds as FGFR inhibitors |
| 03/24/2010 | CN101679406A Thiazolyl compounds useful as kinase inhibitors |
| 03/24/2010 | CN101679405A 2-aminopyridine analogs as glucokinase activators |
| 03/24/2010 | CN101679403A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 |
| 03/24/2010 | CN101679402A Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 |
| 03/24/2010 | CN101679401A 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors |
| 03/24/2010 | CN101679397A Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 03/24/2010 | CN101679396A triazolyl aminopyrimidine compounds |
| 03/24/2010 | CN101679395A triazolyl aminopyrimidine compounds |
| 03/24/2010 | CN101679390A Ground crystal of olmesartan medoxomil |
| 03/24/2010 | CN101679388A Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 03/24/2010 | CN101679387A Aminopyrimidines useful as kinase inhibitors |
| 03/24/2010 | CN101679386A Aminopyrimidines useful as kinase inhibitors |
| 03/24/2010 | CN101679385A Prolinamide-tetrazole derivatives as NK3 receptor antagonists |
| 03/24/2010 | CN101679382A 3-imidazolyl-indoles for the treatment of proliferative diseases |
| 03/24/2010 | CN101679381A Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 03/24/2010 | CN101679379A arylamide pyrimidone compounds |
| 03/24/2010 | CN101679378A Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/24/2010 | CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 03/24/2010 | CN101679373A New solid forms of FXA inhibitors |
| 03/24/2010 | CN101679372A Solid forms of a RAF kinase inhibitor |
| 03/24/2010 | CN101679368A aryloxazole, aryloxadiazole and benzimidazole derivatives |
| 03/24/2010 | CN101679367A Therapeutic agent for cerebral infarction |
| 03/24/2010 | CN101679366A pyridyl piperidine orexin receptor antagonists |
| 03/24/2010 | CN101679365A Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 03/24/2010 | CN101679364A heteroarylamide pyrimidone compounds |
| 03/24/2010 | CN101679362A 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -N-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cance |
| 03/24/2010 | CN101679361A Certain substituted amides, method of making, and method of use thereof |
| 03/24/2010 | CN101679359A Quinolines and their therapeutic use |
| 03/24/2010 | CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions |
| 03/24/2010 | CN101679356A Novel crystalline forms of a vegf-r inhibitor |
| 03/24/2010 | CN101679355A benzimidazole cannabinoid agonists |
| 03/24/2010 | CN101679353A A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 |
| 03/24/2010 | CN101679351A Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor |
| 03/24/2010 | CN101679350A Quinoline derivatives for the treatment of inflammatory diseases |
| 03/24/2010 | CN101679349A 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives |
| 03/24/2010 | CN101679348A 5-pyridinone substituted indazoles |
| 03/24/2010 | CN101679346A substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| 03/24/2010 | CN101679340A antitumoral dihydropyran-2-one compounds |
| 03/24/2010 | CN101679339A Method for manufacturing neuraminic acid derivatives |
| 03/24/2010 | CN101679330A metabolites of (thio)carbamoyl-cyclohexane derivatives |
| 03/24/2010 | CN101679329A compositions of tolperisone |
| 03/24/2010 | CN101679328A Prophylactic or therapeutic agent for age-related macular degeneration |
| 03/24/2010 | CN101679327A Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679326A Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679325A modulators of pharmacokinetic properties of therapeutics |
| 03/24/2010 | CN101679324A 吗啉衍生物 Morpholine derivatives |
| 03/24/2010 | CN101679322A Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679321A Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives |
| 03/24/2010 | CN101679317A Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid r |
| 03/24/2010 | CN101679315A Novel piperazine salts as d3/d2 antagonists |
| 03/24/2010 | CN101679314A Compound that is a dual inhibitor of enzymes PDE7 and/or PDE4, pharmaceutical compositions and uses thereof |
| 03/24/2010 | CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease |
| 03/24/2010 | CN101679311A quinazoline compounds |
| 03/24/2010 | CN101679310A Alkynylpyrimidines as Tie2 kinase inhibitors |
| 03/24/2010 | CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 03/24/2010 | CN101679306A Heteroarylamide pyrimidone derivatives |
| 03/24/2010 | CN101679305A Arylamide pyrimidone derivatives |
| 03/24/2010 | CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis |
| 03/24/2010 | CN101679302A Fungicidal pyridazines, method for the production thereof, and use thereof for controlling fungi and agents containing the same |
| 03/24/2010 | CN101679300A Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 03/24/2010 | CN101679298A fused bicyclic heteroaryl derivatives |
| 03/24/2010 | CN101679297A lxr and fxr modulators |
| 03/24/2010 | CN101679296A Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 03/24/2010 | CN101679294A Non-nucleoside reverse transcriptase inhibitors |
| 03/24/2010 | CN101679293A Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 03/24/2010 | CN101679291A Imidazolidine carboxamide derivatives as P2X7 modulators |
| 03/24/2010 | CN101679288A Indazoles used to treat estrogen receptor beta mediated disorders |
| 03/24/2010 | CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |